thiosulfates has been researched along with Kidney Failure, Chronic in 73 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sodium thiosulfate (STS) can be used in hemodialysis patients but therapy is often limited by the development of high anion gap metabolic acidosis." | 3.96 | Sodium-Thiosulfate Induced Life-Threatening Metabolic Acidosis Limiting Treatment of Calciphylaxis. ( George, T; Sohal, R, 2020) |
| "Sodium thiosulfate was used to treat penile calciphylaxis in 23." | 3.01 | Risk factors, treatment modalities, and clinical outcomes of penile calciphylaxis: systematic review. ( Susantitaphong, P; Takkavatakarn, K; Wipattanakitcharoen, A, 2023) |
| "Calciphylaxis is a rare and devastating condition with important systemic ramifications." | 2.82 | Calciphylaxis: Treatment and outlook-CME part II. ( Chand, S; Kroshinsky, D; Micheletti, R; Ortega-Loayza, AG; Pasieka, HB; Rick, J; Rrapi, R; Shinohara, MM; Strowd, L, 2022) |
| "STS treatment is feasible, appears safe and may decrease the rate of progression of vascular calcification in hemodialysis patients." | 2.76 | Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy. ( Bierhals, A; Cabellon, A; Davila-Roman, VG; de Las Fuentes, L; Delmez, JA; Mathews, SJ; Podaralla, P; Slatopolsky, E; Spence, K; Zheng, S, 2011) |
| "Calciphylaxis is a very complicated disease that usually presents in patients with end-stage renal disease (ESRD)." | 2.61 | Successful Treatment of Single Infected Calciphylaxis Lesion With Intralesional Injection of Sodium Thiosulfate at High Concentration. ( Al-Talib, K; Zuhaili, B, 2019) |
| "Calciphylaxis is a rare disorder of poor prognosis that can lead to intense, painful lesions involving the skin and subcutaneous tissue." | 2.61 | Calciphylaxis: Approach to Diagnosis and Management. ( Noureddine, L; Seethapathy, H, 2019) |
| "Knowledge of advancement in the treatment of calciphylaxis, which was previously a highly fatal disease, is important for physicians and other professionals from various medical fields." | 2.61 | Successful treatment of extensive uremic calciphylaxis with intravenous sodium thiosulfate and its potential in treating various diseases of pathologic calcification. ( Breznik, V; Burja, S; Ekart, R; Jovic, A; Miljkovic, J; Piko, N, 2019) |
| "Calciphylaxis is a cutaneous ischemic infarct caused by total occlusion of blood vessels initiated by vascular calcification." | 2.61 | Calciphylaxis: Diagnosis, Pathogenesis, and Treatment. ( Chang, JJ, 2019) |
| "Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific literature many decades ago." | 2.52 | Calciphylaxis: risk factors, diagnosis, and treatment. ( Goverman, J; Jackson, VA; Kamdar, MM; Kroshinsky, D; Malhotra, R; Nazarian, RM; Nigwekar, SU; Steele, DJ; Thadhani, RI, 2015) |
| "Calciphylaxis is a very uncommon and severe disease which mainly appears in patients with chronic renal insufficiency." | 2.43 | Calciphylaxis: no therapeutic concepts for a poorly understood syndrome? ( Gille, J; Kaufmann, R; Meissner, M, 2006) |
| "Calciphylaxis is a rare disease characterized by calcification of the middle layer of small arteries and arterioles, causing secondary cuta-neous ischemia." | 1.91 | Intralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis. ( Ana, T; Anamá, DP; Carolina, V; Denys, P; Guido, MC; Luis, M; María, D; Paula, E, 2023) |
| "Our experience suggests that the treatment of calciphylaxis requires timely and multi-angle intervention." | 1.72 | Success of small-dose fractionated sodium thiosulfate in the treatment of calciphylaxis in a peritoneal dialysis patient. ( Lu, Y; Shen, L; Xu, D; Zhou, L, 2022) |
| "Calciphylaxis has poor prognosis which often results in amputation and high mortality." | 1.62 | Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain. ( Li, X; Liu, H; Liu, Y; Ni, H; Yang, C; Zhang, X, 2021) |
| "Calciphylaxis is an infrequent disease that almost exclusively affects patients with chronic kidney disease, although cases have been observed in patients without renal function impairment." | 1.48 | Sodium thiosulfate and pamidronate for treatment of calciphylaxis: case report. ( Alvarez, CL; Estifan Ksabji, J; Fernández Cañabate, S; Ortega Valin, L, 2018) |
| " Intravenous sodium thiosulfate was given in a dosage of 12." | 1.43 | Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis. ( Bardin, T; Ea, HK; Malbos, S; Ureña-Torres, P, 2016) |
| "The key to successful treatment of calciphylaxis is fast diagnosing of the disease and appropriate treatment management." | 1.42 | [Calcific uremic arteriolopathy - treatment with sodium thiosulfate]. ( Blaštíková, J; Dvořáková, G; Souček, M; Svojanovský, J; Vyskočilová, M, 2015) |
| "Calciphylaxis is a rare disease in which the treatment is basically supportive." | 1.42 | Penile and generalised calciphylaxis in peritoneal dialysis. ( Sarkis, E, 2015) |
| "ESRD was secondary to nephronophthisis (n = 1), membranoproliferative glomerulonephritis (n = 1), diabetic nephropathy (n = 1), and thrombotic microangiopathy (n = 1)." | 1.40 | Sodium thiosulphate treatment of uraemic tumoral calcinosis. ( Bardin, T; Cohen-Solal, M; Ea, HK; Lioté, F; Malbos, S; Trout, H; Urena-Torres, P, 2014) |
| "Calciphylaxis is a rare and severe disease with an annual incidence of around 1 % in dialysis patients." | 1.40 | [Incidence and characteristics of calciphylaxis in Martinique (2006-2012)]. ( Aoun, A; Banydeen, R; Baubion, E; Derancourt, C; Djiconkpode, I; Dueymes, JM; Ekindi, N; Quist, D; Riaux, A; Sadreux, T; Ureña-Torres, P, 2014) |
| " Dosage adjustment and close follow-up of patients' acid-base status after STS initiation is necessary." | 1.39 | Severe anion gap acidosis associated with intravenous sodium thiosulfate administration. ( Albright, R; Kashani, K; Lee, S; Mao, M; Qian, Q, 2013) |
| " Although many recent case reports have shown exceptional results and healing with the use of sodium thiosulphate, we did not experience any change in the poor prognosis of our patients with the use of this drug, at a dosage of 5 g thrice weekly endovenously." | 1.39 | Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: report of 4 cases. ( Aldi, M; Cantelli, S; Gaddoni, G; Misciali, C; Odorici, G; Patrizi, A; Savoia, F; Tampieri, E; Tampieri, G, 2013) |
| "Calciphylaxis is a life-threatening complication in patients with end-stage renal disease (ESRD)." | 1.39 | Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. ( Auinger, M; König, M; Lhotta, K; Lingenhel, G; Rudnicki, M; Salmhofer, H; Schilcher, G; Vychytil, A; Wallner, M; Zitt, E, 2013) |
| "Sodium thiosulfate (STS) has reported efficacy, thought to be because solubilizing calcium deposits promote clearance by hemodialysis (HD)." | 1.37 | Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis. ( Derendorf, H; Ross, EA; Singh, RP, 2011) |
| "Treatment with sodium thiosulfate resulted in dramatic scintigraphic improvement." | 1.35 | Bone scan findings in metastatic calcification from calciphylaxis. ( Leslie, WD; Soni, S, 2008) |
| "Cinacalcet has been associated with improved pain control and ulcer healing." | 1.35 | Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. ( Raymond, CB; Wazny, LD, 2008) |
| "Calciphylaxis is an infrequent but severe entity found in chronic dialysis patients." | 1.35 | Use of sodium thiosulfate in the treatment of calciphylaxis. ( Algranati, L; Enz, P; Galimberti, R; Garfi, L; Gelman, R; Giuseppe, LD; Kowalczuk, A; Lizarraga, A; Musso, CG; Vidal, F, 2009) |
| "There has been no recurrence of lesions in the 18 months since the cessation of sodium thiosulfate." | 1.35 | Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate. ( Saker, B; Sinniah, R; Subramaniam, K; Wallace, H, 2008) |
| "Thiocyanate was six to seven times greater in HD patients than in non-smoking controls, and decreases in thiocyanate following dialysis were only 19." | 1.32 | Accumulation of cyanide and thiocyanate in haemodialysis patients. ( Hama, Y; Hasuike, Y; Izumi, M; Miyagawa, K; Moriguchi, R; Naka, M; Nakanishi, T; Nanami, M; Otaki, Y; Takamitsu, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.74) | 18.7374 |
| 1990's | 2 (2.74) | 18.2507 |
| 2000's | 11 (15.07) | 29.6817 |
| 2010's | 46 (63.01) | 24.3611 |
| 2020's | 12 (16.44) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, Y | 1 |
| Shen, L | 2 |
| Zhou, L | 1 |
| Xu, D | 1 |
| Yang, C | 1 |
| Liu, Y | 1 |
| Ni, H | 1 |
| Li, X | 1 |
| Liu, H | 1 |
| Zhang, X | 1 |
| Rick, J | 1 |
| Rrapi, R | 1 |
| Chand, S | 1 |
| Shinohara, MM | 1 |
| Strowd, L | 1 |
| Pasieka, HB | 1 |
| Micheletti, R | 1 |
| Kroshinsky, D | 3 |
| Ortega-Loayza, AG | 1 |
| Wipattanakitcharoen, A | 1 |
| Takkavatakarn, K | 1 |
| Susantitaphong, P | 2 |
| Paula, E | 1 |
| Denys, P | 1 |
| Anamá, DP | 1 |
| María, D | 1 |
| Carolina, V | 1 |
| Ana, T | 1 |
| Luis, M | 1 |
| Guido, MC | 1 |
| Zuhaili, B | 1 |
| Al-Talib, K | 1 |
| Djuric, P | 1 |
| Dimkovic, N | 1 |
| Schlieper, G | 1 |
| Djuric, Z | 1 |
| Pantelic, M | 1 |
| Mitrovic, M | 1 |
| Jankovic, A | 1 |
| Milanov, M | 1 |
| Kuzmanovic Pficer, J | 1 |
| Floege, J | 1 |
| Seethapathy, H | 1 |
| Noureddine, L | 1 |
| Cuomo, V | 1 |
| Riccio, CG | 1 |
| Coppola, S | 1 |
| Sohal, R | 1 |
| George, T | 1 |
| Piccoli, GB | 1 |
| Torreggiani, M | 1 |
| Gendrot, L | 1 |
| Nielsen, L | 1 |
| Li, J | 1 |
| Yan, M | 1 |
| Ren, L | 1 |
| Deng, H | 1 |
| Wen, R | 1 |
| Gabel, CK | 1 |
| Nguyen, ED | 1 |
| Dobry, AS | 1 |
| Baker, O | 1 |
| Garza-Mayers, AC | 1 |
| Ko, LN | 1 |
| Shah, R | 1 |
| St John, J | 1 |
| Strazzula, L | 1 |
| Nigwekar, SU | 3 |
| Bian, Z | 1 |
| Zhang, Q | 1 |
| Feng, Y | 1 |
| Chen, S | 1 |
| Mateos Egido, E | 1 |
| Álamo Medina, A | 1 |
| Ródenas Gálvez, AC | 1 |
| Lombardero Pin, M | 1 |
| Díez Del Pino, A | 1 |
| De Miguel Bouzas, JC | 1 |
| Castro Tubío, E | 1 |
| Villamayor Blanco, L | 1 |
| Olaoye, OA | 1 |
| Koratala, A | 1 |
| Santos, PW | 1 |
| He, J | 1 |
| Tuffaha, A | 1 |
| Wetmore, JB | 1 |
| Saengpanit, D | 1 |
| Chattranukulchai, P | 1 |
| Tumkosit, M | 1 |
| Siribumrungwong, M | 1 |
| Katavetin, P | 1 |
| Sitprija, V | 1 |
| Praditpornsilpa, K | 1 |
| Eiam-Ong, S | 1 |
| Darres, A | 1 |
| Delaval, R | 1 |
| Fournier, A | 1 |
| Tournier, E | 1 |
| Cointault, O | 1 |
| Moussion, F | 1 |
| Chauveau, D | 1 |
| Seigneuric, B | 1 |
| Lumbroso, C | 1 |
| Kamar, N | 1 |
| Ribes, D | 1 |
| Leou, S | 1 |
| Huart, A | 1 |
| Testevuide, P | 1 |
| Faguer, S | 1 |
| Ishikawa, M | 1 |
| Motegi, SI | 1 |
| Toki, S | 1 |
| Endo, Y | 1 |
| Yasuda, M | 1 |
| Ishikawa, O | 1 |
| Fernández Cañabate, S | 1 |
| Alvarez, CL | 1 |
| Ortega Valin, L | 1 |
| Estifan Ksabji, J | 1 |
| Burja, S | 1 |
| Jovic, A | 1 |
| Ekart, R | 1 |
| Piko, N | 1 |
| Miljkovic, J | 1 |
| Breznik, V | 1 |
| Chang, JJ | 1 |
| Shen, C | 1 |
| Zhou, Y | 1 |
| Chen, Z | 1 |
| Rao, L | 1 |
| Rodelo-Haad, C | 1 |
| Esquivias-Motta, E | 1 |
| Amaral-Neiva, F | 1 |
| Martin-Malo, A | 1 |
| Aljama, P | 1 |
| Rodriguez, M | 1 |
| Piscitani, L | 1 |
| Sirolli, V | 1 |
| Di Vito, R | 1 |
| Muscianese, P | 1 |
| Brummer, UFM | 1 |
| Di Liberato, L | 1 |
| Bonomini, M | 1 |
| Mao, M | 1 |
| Lee, S | 1 |
| Kashani, K | 1 |
| Albright, R | 1 |
| Qian, Q | 1 |
| Christie, M | 1 |
| Roscoe, J | 1 |
| Chee, J | 1 |
| Inparajah, M | 1 |
| Vaughn-Neil, T | 1 |
| Nagai, G | 1 |
| Ng, P | 1 |
| Fung, J | 1 |
| Ting, R | 1 |
| Tam, P | 1 |
| Sikaneta, T | 1 |
| Savoia, F | 1 |
| Gaddoni, G | 1 |
| Patrizi, A | 1 |
| Misciali, C | 1 |
| Odorici, G | 1 |
| Tampieri, G | 1 |
| Tampieri, E | 1 |
| Cantelli, S | 1 |
| Aldi, M | 1 |
| Brucculeri, M | 1 |
| Rullan, E | 1 |
| Zanchi, A | 1 |
| Marcotte, A | 1 |
| Malbos, S | 2 |
| Urena-Torres, P | 3 |
| Cohen-Solal, M | 1 |
| Trout, H | 1 |
| Lioté, F | 1 |
| Bardin, T | 2 |
| Ea, HK | 2 |
| van den Berg, E | 1 |
| Pasch, A | 1 |
| Westendorp, WH | 1 |
| Navis, G | 1 |
| Brink, EJ | 1 |
| Gans, RO | 1 |
| van Goor, H | 1 |
| Bakker, SJ | 1 |
| Aoun, A | 1 |
| Baubion, E | 1 |
| Banydeen, R | 1 |
| Djiconkpode, I | 1 |
| Ekindi, N | 1 |
| Riaux, A | 1 |
| Sadreux, T | 1 |
| Dueymes, JM | 1 |
| Quist, D | 1 |
| Derancourt, C | 1 |
| Brandenburg, VM | 1 |
| Cozzolino, M | 1 |
| Mazzaferro, S | 1 |
| Vyskočilová, M | 1 |
| Svojanovský, J | 1 |
| Blaštíková, J | 1 |
| Dvořáková, G | 1 |
| Souček, M | 1 |
| Sarkis, E | 1 |
| Nazarian, RM | 1 |
| Goverman, J | 1 |
| Malhotra, R | 1 |
| Jackson, VA | 1 |
| Kamdar, MM | 1 |
| Steele, DJ | 1 |
| Thadhani, RI | 1 |
| Dusilová Sulková, S | 1 |
| Lonowski, S | 1 |
| Martin, S | 1 |
| Worswick, S | 1 |
| Disbrow, MB | 1 |
| Qaqish, I | 1 |
| Kransdorf, M | 1 |
| Chakkera, HA | 1 |
| Young, G | 1 |
| Putt, T | 1 |
| Schollum, J | 1 |
| Walker, R | 1 |
| Hundemer, GL | 1 |
| Fenves, AZ | 1 |
| Phillips, KM | 1 |
| Emmett, M | 1 |
| Ossorio-García, L | 1 |
| Jiménez-Gallo, D | 1 |
| Arjona-Aguilera, C | 1 |
| Linares-Barrios, M | 1 |
| Soni, S | 1 |
| Leslie, WD | 1 |
| Raymond, CB | 2 |
| Wazny, LD | 2 |
| Jikki, PN | 1 |
| Musso, CG | 1 |
| Enz, P | 1 |
| Vidal, F | 1 |
| Gelman, R | 1 |
| Lizarraga, A | 1 |
| Giuseppe, LD | 1 |
| Kowalczuk, A | 1 |
| Garfi, L | 1 |
| Galimberti, R | 1 |
| Algranati, L | 1 |
| Lucas, JL | 1 |
| Rolston, DD | 1 |
| Wollina, U | 2 |
| Sood, AR | 1 |
| Leung, K | 1 |
| Komenda, P | 1 |
| Reslerova, M | 1 |
| Verrelli, M | 1 |
| Rigatto, C | 1 |
| Sood, MM | 1 |
| Mathews, SJ | 1 |
| de Las Fuentes, L | 1 |
| Podaralla, P | 1 |
| Cabellon, A | 1 |
| Zheng, S | 1 |
| Bierhals, A | 1 |
| Spence, K | 1 |
| Slatopolsky, E | 1 |
| Davila-Roman, VG | 1 |
| Delmez, JA | 1 |
| Singh, RP | 1 |
| Derendorf, H | 1 |
| Ross, EA | 2 |
| Salanova Villanueva, L | 1 |
| Sánchez González, MC | 1 |
| Sánchez Tomero, JA | 1 |
| Sanz, P | 1 |
| Scola, N | 1 |
| Kreuter, A | 1 |
| Baldwin, C | 1 |
| Farah, M | 1 |
| Leung, M | 1 |
| Taylor, P | 1 |
| Werb, R | 1 |
| Kiaii, M | 1 |
| Levin, A | 1 |
| Conde Rivera, O | 1 |
| Camba Caride, M | 1 |
| Novoa Fernández, E | 1 |
| Borrajo Prol, M | 1 |
| Santos Nores, J | 1 |
| Iglesias Lamas, E | 1 |
| López Alarcóon, W | 1 |
| Van Noten, C | 1 |
| Janssen van Doorn, K | 1 |
| Vermander, E | 1 |
| Vlayen, S | 1 |
| Verpooten, GA | 1 |
| Couttenye, MM | 1 |
| Zitt, E | 1 |
| König, M | 1 |
| Vychytil, A | 1 |
| Auinger, M | 1 |
| Wallner, M | 1 |
| Lingenhel, G | 1 |
| Schilcher, G | 1 |
| Rudnicki, M | 1 |
| Salmhofer, H | 1 |
| Lhotta, K | 1 |
| AlBugami, MM | 1 |
| Wilson, JA | 1 |
| Clarke, JR | 1 |
| Soroka, SD | 1 |
| Hasuike, Y | 1 |
| Nakanishi, T | 1 |
| Moriguchi, R | 1 |
| Otaki, Y | 1 |
| Nanami, M | 1 |
| Hama, Y | 1 |
| Naka, M | 1 |
| Miyagawa, K | 1 |
| Izumi, M | 1 |
| Takamitsu, Y | 1 |
| Guerra, G | 1 |
| Shah, RC | 1 |
| Meissner, M | 2 |
| Bauer, R | 1 |
| Beier, C | 1 |
| Betz, C | 1 |
| Wolter, M | 1 |
| Kaufmann, R | 2 |
| Gille, J | 2 |
| Mataic, D | 1 |
| Bastani, B | 1 |
| Köstler, E | 1 |
| Subramaniam, K | 1 |
| Wallace, H | 1 |
| Sinniah, R | 1 |
| Saker, B | 1 |
| Papadakis, JT | 1 |
| Patrikarea, A | 1 |
| Digenis, GE | 1 |
| Stamatelou, K | 1 |
| Ntaountaki, I | 1 |
| Athanasopoulos, V | 1 |
| Tamvakis, N | 1 |
| Kyriakopoulos, G | 1 |
| Kontogianni, K | 1 |
| Maruyama, M | 1 |
| Noda, T | 1 |
| Kiyozuka, Y | 1 |
| Oku, M | 1 |
| Ninomiya, Y | 1 |
| Ibaraki, T | 1 |
| Katoh, Y | 1 |
| Itani, Y | 1 |
| Okamura, Y | 1 |
| Beppu, K | 1 |
| Korz, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Partners Calciphylaxis Biobank and Patient Registry[NCT03032835] | 300 participants (Anticipated) | Observational [Patient Registry] | 2017-01-31 | Recruiting | |||
| Randomized Placebo-controlled Trial of the Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis.[NCT06155578] | Phase 1/Phase 2 | 20 participants (Anticipated) | Interventional | 2024-01-02 | Not yet recruiting | ||
| National Follow-up of Dialysis Patients With Sodium Thiosufate-treated Calciphylaxis Under Temporary Use Authorization[NCT03146793] | 600 participants (Anticipated) | Observational | 2017-05-01 | Recruiting | |||
| European Calciphylaxis Registry Network[NCT02635373] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2015-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for thiosulfates and Kidney Failure, Chronic
| Article | Year |
|---|---|
Calciphylaxis: Treatment and outlook-CME part II.
Topics: Calciphylaxis; Female; Humans; Kidney Failure, Chronic; Male; Thiosulfates | 2022 |
Risk factors, treatment modalities, and clinical outcomes of penile calciphylaxis: systematic review.
Topics: Calciphylaxis; Humans; Kidney Failure, Chronic; Male; Penis; Risk Factors; Thiosulfates | 2023 |
Successful Treatment of Single Infected Calciphylaxis Lesion With Intralesional Injection of Sodium Thiosulfate at High Concentration.
Topics: Anti-Bacterial Agents; Calciphylaxis; Chelating Agents; Diabetic Nephropathies; Humans; Injections, | 2019 |
Calciphylaxis: Approach to Diagnosis and Management.
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Microvessels; Pain Management; Ren | 2019 |
Successful treatment of extensive uremic calciphylaxis with intravenous sodium thiosulfate and its potential in treating various diseases of pathologic calcification.
Topics: Aged; Calciphylaxis; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney Failure, Chro | 2019 |
Calciphylaxis: Diagnosis, Pathogenesis, and Treatment.
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Kidney Transplantation; Pain Manag | 2019 |
Calcific uremic arteriolopathy: a call for action.
Topics: Antioxidants; Biomedical Research; Calciphylaxis; Cinacalcet; Diphosphonates; Humans; Kidney Failure | 2014 |
Calciphylaxis: risk factors, diagnosis, and treatment.
Topics: Animals; Arterioles; Biopsy; Calciphylaxis; Case-Control Studies; Chronic Kidney Disease-Mineral and | 2015 |
Multidisciplinary approach to calcific uremic arteriolopathy.
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Risk Factors; Thiosulfates; Uremia | 2015 |
[Cutaneous calciphylaxis].
Topics: Biopsy; Bone Density Conservation Agents; Calciphylaxis; Chelating Agents; Combined Modality Therapy | 2010 |
Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbar | 2006 |
5 trials available for thiosulfates and Kidney Failure, Chronic
| Article | Year |
|---|---|
Sodium thiosulphate and progression of vascular calcification in end-stage renal disease patients: a double-blind, randomized, placebo-controlled study.
Topics: Antioxidants; Aorta, Abdominal; Carotid Intima-Media Thickness; Disease Progression; Double-Blind Me | 2020 |
The Effect of Sodium Thiosulfate on Coronary Artery Calcification in Hemodialysis Patients.
Topics: Calcium; Coronary Artery Disease; Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis; Thios | 2022 |
Effect of Sodium Thiosulfate on Arterial Stiffness in End-Stage Renal Disease Patients Undergoing Chronic Hemodialysis (Sodium Thiosulfate-Hemodialysis Study): A Randomized Controlled Trial.
Topics: Adult; Aged; Ankle Brachial Index; C-Reactive Protein; Combined Modality Therapy; Coronary Artery Di | 2018 |
Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy.
Topics: Aged; alpha-Fetoproteins; Aorta, Thoracic; Bone Density; C-Reactive Protein; Carotid Arteries; Echoc | 2011 |
Oral sodium thiosulfate as maintenance therapy for calcific uremic arteriolopathy: a case series.
Topics: Administration, Intravenous; Administration, Oral; Aged; Bone and Bones; Calciphylaxis; Chelating Ag | 2013 |
57 other studies available for thiosulfates and Kidney Failure, Chronic
| Article | Year |
|---|---|
Success of small-dose fractionated sodium thiosulfate in the treatment of calciphylaxis in a peritoneal dialysis patient.
Topics: Adult; Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; | 2022 |
Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain.
Topics: Calciphylaxis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pain, Intractable; Renal Insuffic | 2021 |
Intralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis.
Topics: Calciphylaxis; Female; Humans; Kidney Failure, Chronic; Renal Dialysis; Thiosulfates | 2023 |
[Primary hyperoxaluria: case report and therapeutic perspectives].
Topics: Calciphylaxis; Calcium Compounds; Female; Glyoxylates; Hemodiafiltration; Humans; Hyperoxaluria, Pri | 2020 |
Sodium-Thiosulfate Induced Life-Threatening Metabolic Acidosis Limiting Treatment of Calciphylaxis.
Topics: Acidosis; Calciphylaxis; Chelating Agents; Comorbidity; Fatal Outcome; Humans; Kidney Failure, Chron | 2020 |
Setting the clock back: new hope for dialysis patients. Sodium thiosulphate and the regression of vascular calcifications.
Topics: Double-Blind Method; Humans; Kidney Failure, Chronic; Renal Dialysis; Thiosulfates; Vascular Calcifi | 2021 |
Intravenous sodium thiosulfate combined with parathyroidectomy as a cure for uremic tumoral calcinosis in a hemodialysis patient.
Topics: Calcinosis; Humans; Kidney Failure, Chronic; Parathyroidectomy; Renal Dialysis; Thiosulfates | 2021 |
Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thiosulfate.
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Thiosulfates | 2021 |
[Sodium thiosulfate for the treatment of acenocumarol-induced calciphylaxis in a patient with preserved kidney function].
Topics: Acenocoumarol; Aged, 80 and over; Anticoagulants; Antidotes; Calciphylaxis; Female; Humans; Kidney; | 2017 |
[Sodium thiosulfate in the treatment of calcific uremic arteriolopathy (calciphylaxis)].
Topics: Calciphylaxis; Female; Humans; Kidney Failure, Chronic; Thiosulfates; Uricosuric Agents | 2017 |
Patient with ESRD with vascular calcifications and ischaemic complications.
Topics: Fingers; Gangrene; Genitalia, Male; Hemodialysis, Home; Humans; Kidney Failure, Chronic; Male; Middl | 2017 |
Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy.
Topics: Aged; Anticoagulants; Arterioles; Calciphylaxis; Cardiovascular Diseases; Chelating Agents; Debridem | 2017 |
The Effectiveness of Topical Cerium Nitrate-Silver Sulfadiazine Application on Overall Outcome in Patients with Calciphylaxis.
Topics: Administration, Cutaneous; Aged; Anti-Infective Agents, Local; Calciphylaxis; Cerium; Chelating Agen | 2019 |
Calciphylaxis and nephrogenic fibrosing dermopathy with pseudoxanthoma elasticum-like changes: Successful treatment with sodium thiosulfate.
Topics: Aged; Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Male; Microscopy, Electron; | 2019 |
Sodium thiosulfate and pamidronate for treatment of calciphylaxis: case report.
Topics: Administration, Intravenous; Aged; Calciphylaxis; Chelating Agents; Drug Therapy, Combination; Femal | 2018 |
Hypercalcemia associated with sodium thiosulfate treatment in a patient with calciphylaxis.
Topics: Adolescent; Breast Diseases; Calciphylaxis; Chelating Agents; Female; Humans; Hypercalcemia; Kidney | 2019 |
Reversing extraosseous calcifications. A case of breast uremic calcific arteriolopathy.
Topics: Arterioles; Breast Diseases; Calcinosis; Ergocalciferols; Female; Humans; Kidney Failure, Chronic; M | 2019 |
[Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy].
Topics: Aged, 80 and over; Calciphylaxis; Conservative Treatment; Female; Humans; Kidney Failure, Chronic; T | 2019 |
Severe anion gap acidosis associated with intravenous sodium thiosulfate administration.
Topics: Acidosis, Renal Tubular; Aged; Antioxidants; Calciphylaxis; Critical Care; Female; Heart Arrest; Hos | 2013 |
Treatment of a hemodialysis patient with pulmonary calcification-associated progressive respiratory failure with sodium thiosulfate.
Topics: Calcinosis; Chelating Agents; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle | 2013 |
Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: report of 4 cases.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Calciphylaxis; Cinacalcet; Combined Modality | 2013 |
Role of sodium thiosulfate therapy in the treatment of digital necrosis due to Mönckeberg sclerosis.
Topics: Diabetes Mellitus, Type 2; Fingers; Gangrene; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mo | 2014 |
Sodium thiosulphate treatment of uraemic tumoral calcinosis.
Topics: Aged; Calcinosis; Comorbidity; Female; Humans; Hypertension; Incidence; Kidney Diseases; Kidney Fail | 2014 |
Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients.
Topics: Adult; Aged; Amino Acids, Sulfur; Cardiovascular Diseases; Female; Humans; Kaplan-Meier Estimate; Ki | 2014 |
[Incidence and characteristics of calciphylaxis in Martinique (2006-2012)].
Topics: Amputation, Surgical; Calciphylaxis; Female; Humans; Hyperparathyroidism, Secondary; Incidence; Kidn | 2014 |
[Calcific uremic arteriolopathy - treatment with sodium thiosulfate].
Topics: Calciphylaxis; Chelating Agents; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Ma | 2015 |
Penile and generalised calciphylaxis in peritoneal dialysis.
Topics: Anti-Bacterial Agents; Calciphylaxis; Debridement; Humans; Kidney Failure, Chronic; Male; Middle Age | 2015 |
[Calcific uremic arteriolopathy].
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Thiosulfates | 2015 |
Widespread calciphylaxis and normal renal function: no improvement with sodium thiosulfate.
Topics: Adult; Biopsy; Calciphylaxis; Chelating Agents; Delayed Graft Function; Female; Follow-Up Studies; G | 2015 |
Calcific uraemic arteriolopathy.
Topics: Adult; Arterioles; Calciphylaxis; Calcium; Chelating Agents; Female; Humans; Kidney Failure, Chronic | 2015 |
Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis.
Topics: Aged; Aged, 80 and over; Antioxidants; Arterioles; Calciphylaxis; Female; Humans; Kidney Failure, Ch | 2016 |
Tumoural calcinosis in a young woman.
Topics: Calcinosis; Chelating Agents; Female; Hand Joints; Humans; Joint Diseases; Kidney Failure, Chronic; | 2016 |
Sodium Thiosulfate and the Anion Gap in Patients Treated by Hemodialysis.
Topics: Acid-Base Equilibrium; Acid-Base Imbalance; Adult; Aged; Calciphylaxis; Chelating Agents; Databases, | 2016 |
Multimodal Treatment of Calciphylaxis With Sodium Thiosulfate, Alprostadil, and Hyperbaric Oxygen Therapy.
Topics: Alprostadil; Calciphylaxis; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Hyper | 2016 |
Bone scan findings in metastatic calcification from calciphylaxis.
Topics: Bone and Bones; Calcinosis; Calciphylaxis; Female; Humans; Ischemia; Kidney Failure, Chronic; Middle | 2008 |
Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis.
Topics: Adult; Aged; Calciphylaxis; Cinacalcet; Diphosphonates; Female; Humans; Kidney Failure, Chronic; Mal | 2008 |
Nephrogenic systemic fibrosis: is gadolinium to be blamed?
Topics: Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic | 2008 |
Use of sodium thiosulfate in the treatment of calciphylaxis.
Topics: Calciphylaxis; Chelating Agents; Female; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Mi | 2009 |
Calciphylaxis (calcific uremic arteriolopathy) in a patient with chronic kidney disease.
Topics: Aged; Anti-Bacterial Agents; Calciphylaxis; Chelating Agents; Dialysis Solutions; Fatal Outcome; Fem | 2010 |
Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series.
Topics: Adult; Arterial Occlusive Diseases; Calciphylaxis; Female; Humans; Kidney Failure, Chronic; Male; Ma | 2011 |
Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis.
Topics: Calciphylaxis; Chelating Agents; Computer Simulation; Dose-Response Relationship, Drug; Humans; Kidn | 2011 |
Successful treatment with sodium thiosulfate for calcific uraemic arteriolopathy.
Topics: Aged; Calciphylaxis; Humans; Kidney Failure, Chronic; Male; Remission Induction; Thiosulfates; Uremi | 2011 |
Calciphylaxis: a severe complication of renal disease.
Topics: Adrenal Cortex Hormones; Calciphylaxis; Chelating Agents; Cinacalcet; Humans; Ischemia; Kidney Failu | 2011 |
Multi-intervention management of calciphylaxis: a report of 7 cases.
Topics: Adult; Aged; Aged, 80 and over; Arterioles; Calciphylaxis; Chelating Agents; Cinacalcet; Combined Mo | 2011 |
Multidisciplinary treatment. A therapeutic option to treat calciphylaxis.
Topics: Anti-Bacterial Agents; Antiphospholipid Syndrome; Calciphylaxis; Carcinoma, Renal Cell; Cardiovascul | 2011 |
Maximal conservative therapy of calcific uremic ateriolopathy.
Topics: Arterioles; Calcimimetic Agents; Chelating Agents; Cinacalcet; Combined Modality Therapy; Diabetes M | 2012 |
Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.
Topics: Aged; Calciphylaxis; Chelating Agents; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; M | 2013 |
Accumulation of cyanide and thiocyanate in haemodialysis patients.
Topics: Adult; Chromatography, High Pressure Liquid; Cyanides; Cysteine; Erythrocytes; Female; Humans; Kidne | 2004 |
Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report.
Topics: Calciphylaxis; Calcium; Calcium Chloride; Female; Hemofiltration; Humans; Kidney Failure, Chronic; M | 2005 |
Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis.
Topics: Abdomen; Adult; Biopsy; Buttocks; Calciphylaxis; Chelating Agents; Female; Humans; Kidney Failure, C | 2006 |
Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis.
Topics: Adolescent; Calciphylaxis; Chelating Agents; Female; Glomerulosclerosis, Focal Segmental; Humans; Hy | 2006 |
[Reader's letter on Marcus Meissner, Jens, Gille, Roland Kaufmann. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?].
Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbar | 2007 |
Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate.
Topics: Antioxidants; Calciphylaxis; Chelating Agents; Female; Humans; Infusions, Intravenous; Kidney Failur | 2008 |
Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism.
Topics: Antioxidants; Calcinosis; Chelating Agents; Female; Humans; Hyperparathyroidism; Joint Diseases; Kid | 1996 |
Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease.
Topics: Calcinosis; Female; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Thiosulfates | 1990 |
[A case report of advanced ovarian cancer with chronic renal dysfunction treated by CDDP i.p].
Topics: Cisplatin; Drug Administration Schedule; Female; Humans; Injections; Kidney Failure, Chronic; Middle | 1988 |
[Intraerythrocytic cyanide metabolism in chronic renal insufficiency].
Topics: Adrenal Glands; Animals; Cyanides; Erythrocytes; Humans; In Vitro Techniques; Iron; Kidney Failure, | 1973 |